indicating optimal immuno-oncology(English)
- allows more patients with esophageal cancer to respond, however it is likely that personalized immunotherapy may be required for the majority
- CPS, DCI, PD-1, PD-L1
- Oncology, Chemotherapy, Precision medicine, Mouth, esophagus and stomach, Therapeutic approaches
- https://doi.org…000000000000542